The "Celiac Disease Treatment Market by Treatment, by Route of Administration, by Distribution Channel, and By Region" report ...
Almost half of Canadian households that have children with celiac disease are struggling to afford gluten-free foods, ...
Patients with celiac disease face an increased risk of developing any chronic liver disease. This risk increase can persist ...
The study data serves as the first symptomatic clinical proof of concept for KAN-101 and its potential as a disease-modifying treatment for celiac disease. KAN-101 induces antigen-specific immune ...
Almost half of Canadian households that have children with celiac disease are struggling to afford gluten-free foods, ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Celiac disease treatment market by Treatment, by Route of Administration, by Distribution Channel, and By Region ...
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced positive symptom data from its Phase 2 ACeD-it trial ...
Patients with celiac disease face a significantly higher risk of developing chronic liver diseases, a risk that persists for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results